Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aseptic loosening.

P H Wooley1, E M Schwarz

  • 1Department of Orthopaedic Surgery, Wayne State University School of Medicine, Detroit, MI 48201, USA.

Gene Therapy
|January 16, 2004
PubMed
Summary
This summary is machine-generated.

Bone loss around implants, known as osteolysis, causes aseptic loosening. This review explores experimental gene therapy as a potential solution for this common complication of joint replacement surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone infection: a clinical priority for clinicians, scientists and educators.

European cells & materials·2021
Same author

IgG4-specific responses in patients with Staphylococcus aureus bone infections are not predictive of postoperative complications.

European cells & materials·2021
Same author

Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitis.

European cells & materials·2020
Same author

A murine femoral ostectomy model with hardware exchange to assess antibiotic-impregnated spacers for implant-associated osteomyelitis.

European cells & materials·2019
Same author

A large animal model for a failed two-stage revision of intramedullary nail-related infection by methicillin-resistant Staphylococcus aureus.

European cells & materials·2017
Same author

Understanding Haemonchus contortus Better Through Genomics and Transcriptomics.

Advances in parasitology·2016
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Area of Science:

  • Biomedical Engineering
  • Orthopedic Surgery
  • Molecular Biology

Background:

  • Total joint replacement is highly successful, but osteolysis (bone loss) around implants causes aseptic loosening.
  • Wear debris from implants triggers inflammation and bone-resorbing osteoclasts, leading to loosening.
  • Current non-surgical treatments for aseptic loosening are ineffective.

Purpose of the Study:

  • To review the current understanding of osteolysis and aseptic loosening.
  • To explore the potential of gene transfer and experimental gene therapy for treating aseptic loosening.

Main Methods:

  • Literature review of osteolysis mechanisms.
  • Analysis of experimental gene therapy approaches for prosthetic implant applications.

Related Experiment Videos

Main Results:

  • Wear debris particles are identified as the primary cause of osteolysis.
  • Gene transfer presents a novel therapeutic avenue for aseptic loosening.
  • Various experimental gene therapy strategies have been investigated.

Conclusions:

  • Aseptic loosening remains a significant challenge in joint replacement surgery.
  • Gene therapy offers promising, novel strategies to address bone loss and implant loosening.
  • Further research into experimental gene therapy is warranted for clinical application.